Protara Therapeutics, Inc. Board of Directors

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy that is in Phase II clinical trial for patients receiving parenteral nutrition. The company is headquartered in New York, New York.

Mr. Jesse Shefferman

Mr. Jesse Shefferman

Co-founder, CEO, President & Director

Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.

Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.

Co-Founder, Senior VP & Chief Scientific Operations Officer

Ms. Justine O'Malley

Ms. Justine O'Malley

Senior Vice President of Investor Relations & Corporate Affairs

Mr. Patrick Fabbio M.B.A.

Mr. Patrick Fabbio M.B.A.

Chief Financial Officer

Ms. Hannah Fry

Ms. Hannah Fry

VP, Principal Accounting Officer & Controller

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.